Moneycontrol PRO
HomeNewsBusinessMarketsStocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March

Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March

Stocks to Watch, Mar 7: Stocks like Tamilnad Mercantile Bank, NMDC, Jindal Stainless, Sudarshan Pharma Industries, Brigade Enterprises, Rail Vikas Nigam, RITES, Laurus Labs, Bharat Electronics, InterGlobe Aviation, Firstsource Solutions, TCPL Packaging, Avanti Feeds, Campus Activewear, and Balaji Phosphates will be in focus on March 7.

March 07, 2025 / 03:08 IST
Stocks to Watch Today
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, appointments and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:

    Stocks to Watch

    Tata Consultancy Services (TCS)

    The IT services company has signed an expanded deal with Northern Trust, a global financial institution, to centralize and standardize its custody operations across 99 direct and global markets. TCS will deploy its comprehensive TCS BaNCSTM Global Securities Platform for Northern Trust, which has $17.4 trillion in assets under custody and administration as of December 2024.

    Power Grid Corporation of India

    Power Grid has been declared the successful bidder to establish an inter-state transmission system in Andhra Pradesh. It has received a Letter of Intent for the project, which comprises the augmentation of transformation capacity at the existing Kurnool-III substation and extension works at the existing C’peta substation, along with a 765kV D/C transmission line.

    Quess Corp

    The business services company has received the approval of the Composite Scheme of Arrangement for the demerger from the National Company Law Tribunal (NCLT), Bangalore, leading to the creation of three publicly listed entities. Upon the demerger, all Quess Corp shareholders on the record date will receive one equity share in each of the resulting companies for every equity share held in Quess Corp.

    Tamilnad Mercantile Bank

    The bank has revised its one-year marginal cost of funds-based lending rate (MCLR) to 9.60% from 9.75% earlier, and its repo-linked lending rate (RLLR) to 9.25% from 9.45% earlier, effective March 7.

    NMDC

    The Government of India has appointed Amitava Mukherjee as Chairman & Managing Director on the board of the company, effective March 6.

    Eris Lifesciences

    As part of Eris Group's internal restructuring of its holdings, the company has transferred 100% of its holdings in two entities—Eris Oaknet Healthcare and Aprica Healthcare—to its subsidiary Eris Therapeutics, for Rs 861.9 crore.

    Jindal Stainless

    The company has completed the divestment of its 26% stake in Jindal Coke for Rs 194.89 crore. With this, Jindal Coke has ceased to be an associate of the company.

    Sudarshan Pharma Industries

    Sachin Mehta has resigned as Chief Financial Officer of the company, effective April 1, 2025. However, he will continue as the Joint Managing Director of the company. The Board has appointed Manoj Lodha as Executive Director and Chief Financial Officer of the company, effective April 1.

    Omaxe

    The company's subsidiary, Omaxe World Street, has received RERA Registration Certificates from the Haryana Real Estate Regulatory Authority (HRERA) for two of its new commercial projects (New Singapore and Clarkee) in Faridabad, Haryana.

    Brigade Enterprises

    The company has launched a premium residential project—Brigade Altius—in Chennai, spanning 6.5 acres with a total development area of 1.4 million square feet. The project has a revenue potential of Rs 1,700 crore.

    Rail Vikas Nigam

    The company has received a Letter of Acceptance from South Western Railway for a project worth Rs 156.35 crore. The project involves engineering, procurement, and construction (EPC) for the design, supply, erection, testing, and commissioning of a 2X25 KV OHE & PSI system, including electrical general services, engineering, and telecommunication works between Rayadurga and Pavagada.

    Kalpataru Projects International

    The company has secured new orders worth Rs 2,306 crore in the transmission and distribution business in overseas markets, as well as in building projects in India. With these orders, its order intake to date in FY25 has reached around Rs 22,500 crore.

    RITES

    The company has received a Letter of Acceptance from South Central Railway for a project worth Rs 27.9 crore. The project involves carrying out a final location survey for the High-Speed Elevated Rail Corridor between Hyderabad-Bengaluru and Hyderabad-Chennai.

    Laurus Labs

    The board has approved an investment of Rs 83.3 crore in KRKA Pharma, a joint venture of the company. Further, KRKA d.d., Novo mesto, Slovenia (co-venturer), will also invest Rs 86.7 crore in KRKA. With this, they will maintain the existing shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs. The purpose of this investment is to acquire land and meet the initial cost of setting up a manufacturing facility for the production of finished products for new markets, including the Indian market.

    Bharat Electronics

    The company has secured additional orders worth Rs 577 crore since February 20. Major orders include airborne electronic warfare products, advanced composite communication systems for submarines, Doppler weather radar, train communication systems, radar upgrades, spares, services, etc. With these, the total accumulated orders received by BEL during the current financial year stand at Rs 13,724 crore.

    Biocon

    The company's subsidiary, Biocon Biologics, announced a strategic collaboration agreement with Civica, Inc. to expand access and affordability of Insulin Aspart in the United States. As per the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., which will use the drug substance to produce Insulin Aspart drug products, a rapid-acting insulin analog, at its manufacturing facility in Petersburg, Virginia.

    InterGlobe Aviation

    IndiGo, with its long-haul debut, announced non-stop flights to Manchester and Amsterdam. The service to Manchester will be the only direct route from India to the North of the UK. The operations are expected to commence during the summer schedule from July 2025.

    Firstsource Solutions

    The RP-Sanjiv Goenka Group company announced the launch of its Agentic AI Studio, a solution designed to transform the future of work.

    TCPL Packaging

    The company has inaugurated its new greenfield facility in Chennai, which will increase its capacity to manufacture paperboard cartons and strengthen its pan-India presence, enhance logistics, and improve service capabilities.

    Block Deals

    Avanti Feeds

    IIFL Facilities Services acquired a 4.38% stake in the company at an average price of Rs 786 per share from Thai Union Asia Investment Holding, amounting to Rs 469.8 crore.

    Campus Activewear

    Fidelity India Fund and Fidelity Funds - India Focus Fund bought an additional 1.63% stake in the company at an average price of Rs 258.5 per share from promoter Hari Krishan Agarwal, valued at Rs 129.25 crore.

    SME Listing on March 7

    Balaji Phosphates

    Stocks Trade Ex-Dividend

    SBI Life Insurance Company
    Metro Brands

    Stock Trades Ex-Date for Bonus & Split

    Pradhin

    Stock Trades Ex-Date for Rights

    Bisil Plast

    Stock Trades Ex-Date for Resolution Plan - Suspension

    Birla Cotsyn (India)

    Stocks in F&O ban

    Manappuram Finance

    Sunil Shankar Matkar
    first published: Mar 7, 2025 03:08 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347